Related Experiment Video

Updated: Jun 17, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Expression of pSTAT5 predicts FLT3 internal tandem duplications in acute myeloid leukemia

Ellen Christina Obermann1, Caroline Arber, Martine Jotterand

  • 1Institute of Pathology, University of Basel, Schönbeinstrasse 40, 4031 Basel, Switzerland.

Annals of Hematology
|January 13, 2010
PubMed

Insights

Phosphorylated signal transducer and activator of transcription 5 (pSTAT5) expression in leukemic blasts predicts Fms-like tyrosine kinase 3 (FLT3) mutations in acute myeloid leukemia (AML). This finding aids in diagnosing AML and understanding FLT3 signaling pathways.

Area of Science:

  • Hematology
  • Molecular Biology
  • Oncology

Background:

  • Fms-like tyrosine kinase 3 (FLT3) mutations are common in acute myeloid leukemia (AML).
  • Identifying FLT3 mutations is crucial for AML diagnosis and treatment strategies.
  • The role of downstream signaling pathways, such as STAT proteins, in FLT3-mutated AML requires further elucidation.

Purpose of the Study:

  • To investigate the association between FLT3-internal tandem duplications (ITD) and the expression of phosphorylated signal transducer and activator of transcription (pSTAT) proteins in AML.
  • To determine if pSTAT5 expression in leukemic blasts can serve as a predictive marker for FLT3-ITD.
  • To assess the utility of immunohistochemistry for evaluating pSTAT protein expression in routine bone marrow trephine biopsies.

Main Methods:

  • Seventy-five AML cases were analyzed for FLT3-ITD using polymerase chain reaction.
  • Expression of pSTAT1, pSTAT3, and pSTAT5 was assessed in bone marrow trephine biopsies via immunohistochemistry.
  • Double staining with a blast-specific marker was employed to confirm pSTAT5 expression in leukemic blasts.

Main Results:

  • Expression of pSTAT5 in >=1% of leukemic blasts was highly predictive of FLT3-ITD.
  • Neither pSTAT1 nor pSTAT3 expression showed an association with FLT3 mutations.
  • Immunohistochemistry reliably detected pSTAT5 expression in routinely processed bone marrow trephines.

Conclusions:

  • pSTAT5 expression is a precise indicator of FLT3-ITD in AML.
  • STAT5 is likely the primary second messenger in FLT3-mediated signaling in AML.
  • Assessing pSTAT5 expression via immunohistochemistry is a valuable tool for AML research and clinical practice.

More Related Videos

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts11:19

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts

Published on: October 9, 2016

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...